Search Results - M Hus
- Showing 1 - 4 results of 4
-
1
EFFICACY AND SAFETY OF NEMTABRUTINIB VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WITHOUT TUMOR PROTEIN 5... by G Perini, M Hus, S Wu, P Ilonczai, C Chen, J Yang, M Farooqui, A Mcdonald
Published in Hematology, Transfusion and Cell Therapy (2023-10-01)Get full text
Article -
2
C008 | PHASE III COMMODORE 2 AND 1 TRIALS: CHARACTERIZATION OF BREAKTHROUGH HEMOLYSIS EVENTS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB OR ECULIZU... by R. Notaro, A. G. Kulasekararaj, J. Czyz, C. Flynn, G. Roncone Gastal, M. Hus, C. Lalayanni, E. Nur, P. Scheinberg, Y. Ueda, A. M. Vannucchi, M. Vidriales Vicente, I. Viigimaa, S. Buatois, A. C. Chang, S. Chebon, A. Röth
Published in Haematologica (2025-09-01)Get full text
Article -
3
P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRM... by A. Nooka, S. Lonial, S. Grosicki, M. Hus, K. Song, T. Facon, N. S. Callander, V. Ribrag, K. Uttervall, H. Quach, V. Vorobyev, C.-K. Min, S. Cheng, L. M. Smith, J. Yu, T. Collingwood, B. Holkova, B. E. Kremer, I. V. Gupta, P. G. Richardson, M. C. Minnema
Published in HemaSphere (2022-06-01)Get full text
Article -
4
P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA by S. Z. Usmani, M. Mielnik, Y. Koh, A. Alonso Alonso, X. Leleu, H. Quach, C.-K. Min, W. Janowski, A.-O. Abdallah, M. Garg, I. Sandhu, E. M. Ocio San Miguel, A. Oriol, P. Rodriquez-Otero, K. Ramasamy, K. Weisel, B. Besemer, M. Cavo, X. L. Zhou, M. C. Kaisermann, C. M. Bego Marques, D. Williams, F. Carreno, B. E. Kremer, I. V. Gupta, M. Hus
Published in HemaSphere (2022-06-01)Get full text
Article